According to a new report, published by KBV research, The Global Cell Separation Market Market size is expected to reach $17.5 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.
The Instruments segment would witness a CAGR of 11.8% during (2023 - 2030). Companies have started developing sustainable technologies to acquire a competitive edge in the market which is supporting the segment’s growth. For instance, Element Biosciences revealed information about future Aviti DNA sequences in March 2022. The product is anticipated to be a new benchtop instrument since the manufacturer claims it can reduce reagent consumption and cut costs significantly.
The Biotechnology & Biopharmaceutical Companies segment is leading the Global Cell Separation Market by End-Use in 2022; thereby, achieving a market value of $7.2 Billion by 2030. The segment of biotechnology and pharmaceutical companies will rise gradually throughout the projection period due to these companies' rising R&D expenditures for creating new products. These companies are involved in extensive R&D to develop new-generation therapeutics requiring cell separation techniques.
The Human Cell segment would register a CAGR of 11.2% during (2023 - 2030). One of the main drivers driving its highest share is the growing emphasis on human and cancer research and the various uses of isolated human cells in biopharmaceutical development, clinical trials, and research. In addition, favorable reimbursement policies for personalized medicine in developed nations increase the demand for human cell isolation.
The Centrifugation segment acquired highest revenue in the Global Cell Separation Market by Technique in 2022; thereby, achieving a market value of $8.7 billion by 2030. This is a result of the widespread use of this technique by research facilities, biotechnology and pharmaceutical companies, and academic institutions. One of the most significant procedures is centrifugation. The most popular cell separation processes are differential centrifugation and density gradient centrifugation.
The Cancer Research segment is showcasing a CAGR of 9.8% during (2023 - 2030). Growing investment in cell-based research by businesses and academic institutions is a major factor behind the segment's expansion. Due to the rising global incidence of cancer, numerous public-private organizations are investing significantly in cancer research, thereby driving the demand for innovative cell separation solutions.
The North America region dominated the Global Cell Separation Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $6.7 billion by 2030. The Europe market is poised to grow at a CAGR of 10% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 11% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/cell-separation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Corning Incorporated, Terumo Corporation, STEMCELL Technologies, Inc. and Akadeum Life Sciences, Inc.
By Product Type
By End-Use
By Cells Type
By Technique
By Application
By Geography
Companies Profiled
Unique Offerings 
